ARCHIVES

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Majority Of Americans Support Cigarette Tax Increase, Survey Finds

May 28, 1993

Preliminary Budget Asks $876 Million for NCI As Carter, Fredrickson Ignore ZBB Justifications

December 16, 1977

Four NCAB Appointments Announced, Including Durant, Fisher; White House Delays On Others

April 4, 1986

Upton Finds Work For Former Division, Program Directors

September 14, 1979

Abstracts Of Papers From Copenhagen Leukemia Symposium

October 31, 1975

Program Announcements n Animal Retroviruses, Other Topics, Approved

March 30, 1990